The pharmaceutical industry is set to experience significant growth due to global medical demands, an aging population, technological advancements, and government investments in healthcare infrastructure.
Given the industry’s growth prospects, investors could consider buying fundamentally sound pharma stocks Eli Lilly and Company (LLY), Wave Life Sciences Ltd. (WVE) and Johnson & Johnson (JNJ) for solid returns.
